These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 4082148)

  • 1. [Oral contraceptives and antithrombin III].
    Stormorken H
    Tidsskr Nor Laegeforen; 1985 Nov; 105(32):2333. PubMed ID: 4082148
    [No Abstract]   [Full Text] [Related]  

  • 2. [Contraceptive agents and antithrombin III. New causes of thrombosis].
    Abildgaard U; Andersson TR; Try K; Odegaard OR
    Tidsskr Nor Laegeforen; 1986 Feb; 106(4):346-7. PubMed ID: 3961755
    [No Abstract]   [Full Text] [Related]  

  • 3. [Surveillance of women taking oral contraceptives by determination of antithrombin III].
    Benoit MO; Raichvarg D; Caillens H; Neau C
    Nouv Presse Med; 1979 Feb; 8(7):528-9. PubMed ID: 461171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study of the activity of antithrombin-III in latent cholestasis. (A clinico-pharmacological study of the relationship between antithrombin-III activity and steroid cholestasis).
    Horváth T; Nagy I; Gógl A
    Acta Med Acad Sci Hung; 1978; 35(2):105-13. PubMed ID: 742337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inferior vena cava thrombosis with oral contraceptives documented by computed tomography.
    Barter JF; Addison WA; Hidalgo H; Hammond CB
    Obstet Gynecol; 1983 Mar; 61(3 Suppl):59S-62S. PubMed ID: 6681670
    [No Abstract]   [Full Text] [Related]  

  • 6. Evaluation of the prethrombotic state in pregnancy and in women using oral contraceptives.
    Levine AB; Teppa J; McGough B; Cowchock FS
    Contraception; 1996 May; 53(5):255-7. PubMed ID: 8724613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antithrombin III deficiency, deep venous thrombosis, and oral contraceptive use.
    Werner MJ
    J Adolesc Health; 1995 Sep; 17(3):189-92. PubMed ID: 8519788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antithrombin III and oral contraception with progestagen-only preparation.
    Conard J; Samama M; Horellou MN; Zorn JR; Neau C
    Lancet; 1979 Sep; 2(8140):471. PubMed ID: 89530
    [No Abstract]   [Full Text] [Related]  

  • 9. [Antithrombin III in clinical practice].
    Monreal M; Rodríguez R; Monasterio I
    Med Clin (Barc); 1982 Jun 16-30; 79(2):91-3. PubMed ID: 7121115
    [No Abstract]   [Full Text] [Related]  

  • 10. [Significance of hereditary thrombophilia for risk of thrombosis with oral contraceptives].
    Bauersachs R; Lindhoff-Last E; Ehrly AM; Kuhl H
    Zentralbl Gynakol; 1996; 118(5):262-70. PubMed ID: 8701622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombotic risk of women with hereditary antithrombin III-, protein C- and protein S-deficiency taking oral contraceptive medication. The GTH Study Group on Natural Inhibitors.
    Pabinger I; Schneider B
    Thromb Haemost; 1994 May; 71(5):548-52. PubMed ID: 8091378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemostatic effects of oral contraceptives in women who developed deep-vein thrombosis while using oral contraceptives.
    Bloemenkamp KW; Rosendaal FR; Helmerhorst FM; Koster T; Bertina RM; Vandenbroucke JP
    Thromb Haemost; 1998 Sep; 80(3):382-7. PubMed ID: 9759614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral contraceptives and deep venous thrombosis with pulmonary embolism.
    Bouché RT; Medawar SJ; Dockery GL
    J Foot Surg; 1982; 21(4):297-301. PubMed ID: 7186920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The determination of antithrombin III and its clinical application.
    Gray SP; Billings JA
    J R Nav Med Serv; 1979; 65(3):147-51. PubMed ID: 536946
    [No Abstract]   [Full Text] [Related]  

  • 15. [Can the measurement of antithrombin-3 point out women who run the risk of thrombosis with the use of P-pills?].
    Fagerhol MK; Abildgaard U
    Tidsskr Nor Laegeforen; 1970 Aug; 90(16):1559-60. PubMed ID: 5457809
    [No Abstract]   [Full Text] [Related]  

  • 16. [Thrombosis risks and oral contraceptives].
    Asbeck F; Loo van de J
    Med Welt; 1970 Oct; 43():1859-61. PubMed ID: 5475558
    [No Abstract]   [Full Text] [Related]  

  • 17. [Dosage of antithrombin III in women taking oral contraceptives].
    Agoumi N; Messerschmitt C; Nejjar C; Guon VL
    Maghrib Tibbi; 1980 Oct; 2(3):309-15. PubMed ID: 7230892
    [No Abstract]   [Full Text] [Related]  

  • 18. A comparison of antithrombin III procedures.
    Rose M; Wideman CS; Evatt BL; Haff E
    Clin Lab Haematol; 1983; 5(2):185-95. PubMed ID: 6883970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of levenogesterol (Norplant) contraception on coagulation as measured by antithrombin-III levels.
    Pryor JA; Cooper KR; Bass JD; Hampton HL; Rock WA; Morrison JC
    J Miss State Med Assoc; 1996 Oct; 37(10):777-9. PubMed ID: 8908950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombosis and oral contraceptives.
    Bhalgotra S; Arora S; Manhas K
    J Obstet Gynaecol India; 1979 Apr; 29(2):261-3. PubMed ID: 488514
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.